Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Acellular red blood cell substitute

Acellular red blood cell substitute

US Patent 6323320 · Granted Nov 27, 2001

Estimated economic value: $2,797,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vec2016
Vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vector2016
Method of filtering platelets to remove antiplatelet and anticoagulant agents2015
Platelet preservation package comprising a short to ultra-short acting antiplate2015
Methods for removing pathogens from a platelet preparation2014
Composition for preserving platelets during photosensitization2014
Composition for preserving platelets and method of using the same2014
Method for removing antiplatelet agent and anticoagulant from a platelet composi2013
Method for removing antiplatelet agent and anticoagulant from a platelet composi2013
Ex vivo and in vivo expression of the thrombomodulin gene for the treatment of c2013
In vivo and ex vivo gene transfer into renal tissue using gutless adenovirus vec2013
Composition containing short-to-ultrashort GPIIb/IIIa and factor Xa inhibitors a2012